Mason Lab proudly took center stage at the World Molecular Imaging Congress (WMIC) in Prague, September 5th-9th, 2023. This global event brought together experts from academia and industry, fostering collaboration and innovation.
Our team made two impactful presentations, focusing on imaging peripheral artery disease and exploring heme-targeting agents with radiation therapy in small cell lung cancer. These studies showcased Mason Lab's commitment to advancing molecular imaging.
WMIC 2023 featured 76 sessions, including 180 oral presentations and 137 sessions with senior leaders in the field. Four poster sessions highlighted 574 posters presenting new science across diverse topics. With a virtual option, WMIC 2023 reached a global audience, broadcasting each session worldwide.
Mason Lab's participation in WMIC 2023 reflects our dedication to pushing the boundaries of scientific discovery. Stay tuned for more updates as we continue our journey toward groundbreaking research.
At Mason Lab, we illuminate the path to innovation on the global stage.